| Year |
Citation |
Score |
| 2017 |
Cooperstone JL, Tober KL, Riedl KM, Teegarden MD, Cichon MJ, Francis DM, Schwartz SJ, Oberyszyn TM. Tomatoes protect against development of UV-induced keratinocyte carcinoma via metabolomic alterations. Scientific Reports. 7: 5106. PMID 28698610 DOI: 10.1038/S41598-017-05568-7 |
0.473 |
|
| 2017 |
Beesetti S, Mavuluri J, Surabhi RP, Oberyszyn TM, Tober K, Pitani RS, Joseph LD, Venkatraman G, Rayala SK. Transcriptional regulation of ataxia-telangiectasia and Rad3-related protein by activated p21-activated kinase-1 protects keratinocytes in UV-B-induced premalignant skin lesions. Oncogene. PMID 28692051 DOI: 10.1038/Onc.2017.218 |
0.45 |
|
| 2017 |
Teegarden MD, Campbell AR, Cooperstone JL, Tober KL, Schwartz SJ, Oberyszyn TM. 25-Hydroxyvitamin D3 and its C-3 epimer are elevated in the skin and serum of Skh-1 mice supplemented with dietary vitamin D3. Molecular Nutrition & Food Research. PMID 28589636 DOI: 10.1002/Mnfr.201700293 |
0.317 |
|
| 2017 |
Hennessey RC, Holderbaum AM, Bonilla A, Delaney C, Gillahan JE, Tober KL, Oberyszyn TM, Zippin JH, Burd CE. Ultraviolet radiation accelerates NRas-mutant melanomagenesis: a cooperative effect blocked by sunscreen. Pigment Cell & Melanoma Research. PMID 28544727 DOI: 10.1111/Pcmr.12601 |
0.435 |
|
| 2016 |
Abikhair M, Mitsui H, Yanofsky V, Roudiani N, Ovits C, Bryan T, Oberyszyn TM, Tober KL, Gonzalez J, Krueger JG, Felsen D, Carucci JA. Cyclosporine A immunosuppression drives catastrophic squamous cell carcinoma through IL-22. Jci Insight. 1: e86434. PMID 27699266 DOI: 10.1172/Jci.Insight.86434 |
0.338 |
|
| 2016 |
Holderbaum AM, Hennessey RC, Gillahan JE, Bonilla A, Delaney C, Kladney RD, Tober KL, Oberyszyn TM, Burd CE. Abstract 900:In vivomodeling ofNRAS-mutant melanoma reveals differential preventative efficacy amongst SPF30 sunscreens Cancer Research. 76: 900-900. DOI: 10.1158/1538-7445.Am2016-900 |
0.471 |
|
| 2015 |
Kopec RE, Schick J, Tober KL, Riedl KM, Francis DM, Young GS, Schwartz SJ, Oberyszyn TM. Sex differences in skin carotenoid deposition and acute UVB-induced skin damage in SKH-1 hairless mice after consumption of tangerine tomatoes. Molecular Nutrition & Food Research. PMID 26394800 DOI: 10.1002/Mnfr.201500317 |
0.495 |
|
| 2015 |
Gressel KL, Duncan FJ, Oberyszyn TM, La Perle KM, Everts HB. Endogenous Retinoic Acid Required to Maintain the Epidermis Following Ultraviolet Light Exposure in SKH-1 Hairless Mice. Photochemistry and Photobiology. 91: 901-8. PMID 25715879 DOI: 10.1111/Php.12441 |
0.386 |
|
| 2015 |
Braddom A, Richmond T, Sheetz T, Reese E, Tessari A, Tober K, Burd CE, Lorenzo CD, Martin EW, Coppola V, Tweedle MF, Oberyszyn T, Croce CM, Palmieri D. Abstract C171: Human anti-Nucleolin recombinant immunoagents as new potential tools for melanoma treatment Molecular Cancer Therapeutics. 14. DOI: 10.1158/1535-7163.Targ-15-C171 |
0.383 |
|
| 2014 |
Hill NT, Gracia-Maldonado GH, Leonard MK, Harper AR, Tober KL, Oberyszyn TM, Kadakia MP. Role of vitamin D3 in modulation of ΔNp63α expression during UVB induced tumor formation in SKH-1 mice. Plos One. 9: e107052. PMID 25191969 DOI: 10.1371/Journal.Pone.0107052 |
0.416 |
|
| 2014 |
Nagarajan P, Tober KL, Riggenbach JA, Kusewitt DF, Lehman AM, Sielecki T, Pruitt J, Satoskar AR, Oberyszyn TM. MIF antagonist (CPSI-1306) protects against UVB-induced squamous cell carcinoma. Molecular Cancer Research : McR. 12: 1292-302. PMID 24850900 DOI: 10.1158/1541-7786.Mcr-14-0255-T |
0.561 |
|
| 2014 |
Perez CJ, Rundhaug JE, Johnson DG, Oberyszyn TM, Tober KL, Kusewitt DF. Slug expression in mouse skin and skin tumors is not regulated by p53. The Journal of Investigative Dermatology. 134: 566-8. PMID 24008423 DOI: 10.1038/Jid.2013.363 |
0.463 |
|
| 2014 |
Cooperstone J, Tober K, Riedl K, Riggenbach J, Francis D, Schwartz S, Oberyszyn T. Tomato carotenoids protect against UV-induced cutaneous damage and tumor development in Skh-1 hairless mice (645.7) The Faseb Journal. 28. DOI: 10.1096/Fasebj.28.1_Supplement.645.7 |
0.496 |
|
| 2013 |
Burns EM, Tober KL, Riggenbach JA, Kusewitt DF, Young GS, Oberyszyn TM. Extended UVB Exposures Alter Tumorigenesis and Treatment Efficacy in a Murine Model of Cutaneous Squamous Cell Carcinoma. Journal of Skin Cancer. 2013: 246848. PMID 24286011 DOI: 10.1155/2013/246848 |
0.715 |
|
| 2013 |
Johnson KE, Wulff BC, Oberyszyn TM, Wilgus TA. Ultraviolet light exposure stimulates HMGB1 release by keratinocytes. Archives of Dermatological Research. 305: 805-15. PMID 23942756 DOI: 10.1007/S00403-013-1401-2 |
0.771 |
|
| 2013 |
Burns EM, Tober KL, Riggenbach JA, Kusewitt DF, Young GS, Oberyszyn TM. Differential effects of topical vitamin E and C E Ferulic® treatments on ultraviolet light B-induced cutaneous tumor development in Skh-1 mice. Plos One. 8: e63809. PMID 23691100 DOI: 10.1371/Journal.Pone.0063809 |
0.727 |
|
| 2013 |
Burns EM, Tober KL, Riggenbach JA, Schick JS, Lamping KN, Kusewitt DF, Young GS, Oberyszyn TM. Preventative topical diclofenac treatment differentially decreases tumor burden in male and female Skh-1 mice in a model of UVB-induced cutaneous squamous cell carcinoma. Carcinogenesis. 34: 370-7. PMID 23125227 DOI: 10.1093/Carcin/Bgs349 |
0.754 |
|
| 2012 |
Dhabhar FS, Saul AN, Holmes TH, Daugherty C, Neri E, Tillie JM, Kusewitt D, Oberyszyn TM. High-anxious individuals show increased chronic stress burden, decreased protective immunity, and increased cancer progression in a mouse model of squamous cell carcinoma. Plos One. 7: e33069. PMID 22558071 DOI: 10.1371/Journal.Pone.0033069 |
0.774 |
|
| 2012 |
Sullivan NJ, Tober KL, Burns EM, Schick JS, Riggenbach JA, Mace TA, Bill MA, Young GS, Oberyszyn TM, Lesinski GB. UV light B-mediated inhibition of skin catalase activity promotes Gr-1+ CD11b+ myeloid cell expansion. The Journal of Investigative Dermatology. 132: 695-702. PMID 22030957 DOI: 10.1038/Jid.2011.329 |
0.754 |
|
| 2010 |
Dhabhar FS, Saul AN, Daugherty C, Holmes TH, Bouley DM, Oberyszyn TM. Short-term stress enhances cellular immunity and increases early resistance to squamous cell carcinoma. Brain, Behavior, and Immunity. 24: 127-37. PMID 19765644 DOI: 10.1016/J.Bbi.2009.09.004 |
0.756 |
|
| 2010 |
Wulff BC, Thomas-Ahner JM, Schick JS, Oberyszyn TM. Celecoxib reduces the effects of acute and chronic UVB exposure in mice treated with therapeutically relevant immunosuppressive drugs. International Journal of Cancer. 126: 11-8. PMID 19609953 DOI: 10.1002/Ijc.24749 |
0.538 |
|
| 2010 |
Tober KL, Riggenbach JA, Schick JS, Sullivan NJ, Abbaoui L, Oberyszyn TM. Abstract 4202: Sex disparities in the cutaneous response to acute ultraviolet light exposure Cancer Research. 70: 4202-4202. DOI: 10.1158/1538-7445.Am10-4202 |
0.5 |
|
| 2010 |
Sullivan NJ, Schick JS, Riggenbach JA, Tober KL, Hall BM, Oberyszyn TM. Abstract 3378: E-cadherin suppresses breast cancer cell growth and interleukin-6 production Cancer Research. 70: 3378-3378. DOI: 10.1158/1538-7445.Am10-3378 |
0.34 |
|
| 2009 |
Duncan FJ, Martin JR, Wulff BC, Stoner GD, Tober KL, Oberyszyn TM, Kusewitt DF, Van Buskirk AM. Topical treatment with black raspberry extract reduces cutaneous UVB-induced carcinogenesis and inflammation. Cancer Prevention Research (Philadelphia, Pa.). 2: 665-72. PMID 19584078 DOI: 10.1158/1940-6207.Capr-08-0193 |
0.517 |
|
| 2009 |
Sullivan NJ, Sasser AK, Axel AE, Vesuna F, Raman V, Ramirez N, Oberyszyn TM, Hall BM. Interleukin-6 induces an epithelial-mesenchymal transition phenotype in human breast cancer cells. Oncogene. 28: 2940-7. PMID 19581928 DOI: 10.1038/Onc.2009.180 |
0.33 |
|
| 2009 |
Dworkin AM, Tober KL, Duncan FJ, Yu L, VanBuskirk AM, Oberyszyn TM, Toland AE. Chromosomal aberrations in UVB-induced tumors of immunosuppressed mice. Genes, Chromosomes & Cancer. 48: 490-501. PMID 19296524 DOI: 10.1002/Gcc.20657 |
0.377 |
|
| 2009 |
Martin J, Duncan FJ, Keiser T, Shin S, Kusewitt DF, Oberyszyn T, Satoskar AR, VanBuskirk AM. Macrophage migration inhibitory factor (MIF) plays a critical role in pathogenesis of ultraviolet-B (UVB) -induced nonmelanoma skin cancer (NMSC). Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 23: 720-30. PMID 18952710 DOI: 10.1096/Fj.08-119628 |
0.52 |
|
| 2009 |
Benavides F, Oberyszyn TM, VanBuskirk AM, Reeve VE, Kusewitt DF. The hairless mouse in skin research. Journal of Dermatological Science. 53: 10-8. PMID 18938063 DOI: 10.1016/J.Jdermsci.2008.08.012 |
0.473 |
|
| 2008 |
Wulff BC, Kusewitt DF, VanBuskirk AM, Thomas-Ahner JM, Duncan FJ, Oberyszyn TM. Sirolimus reduces the incidence and progression of UVB-induced skin cancer in SKH mice even with co-administration of cyclosporine A. The Journal of Investigative Dermatology. 128: 2467-73. PMID 18463679 DOI: 10.1038/Jid.2008.121 |
0.506 |
|
| 2008 |
Wilgus TA, Ferreira AM, Oberyszyn TM, Bergdall VK, Dipietro LA. Regulation of scar formation by vascular endothelial growth factor. Laboratory Investigation; a Journal of Technical Methods and Pathology. 88: 579-90. PMID 18427552 DOI: 10.1038/Labinvest.2008.36 |
0.664 |
|
| 2008 |
Oberyszyn TM. Non-melanoma skin cancer: importance of gender, immunosuppressive status and vitamin D. Cancer Letters. 261: 127-36. PMID 18267352 DOI: 10.1016/J.Canlet.2008.01.009 |
0.453 |
|
| 2008 |
Visone R, Iuliano R, Palmieri D, Server IN, Chiappetta G, De Martino I, Fedele M, Costinean S, Oberyszyn TM, Kusewitt DF, Croce CM, Fusco A. Hmga1 null mice are less susceptible to chemically induced skin carcinogenesis. European Journal of Cancer (Oxford, England : 1990). 44: 318-25. PMID 18155899 DOI: 10.1016/J.Ejca.2007.11.017 |
0.441 |
|
| 2008 |
Wulff BC, Schick JS, Thomas-Ahner JM, Kusewitt DF, Yarosh DB, Oberyszyn TM. Topical treatment with OGG1 enzyme affects UVB-induced skin carcinogenesis. Photochemistry and Photobiology. 84: 317-21. PMID 18086242 DOI: 10.1111/J.1751-1097.2007.00257.X |
0.526 |
|
| 2008 |
Wilgus T, Bergdall V, DiPietro L, Oberyszyn T. 167
The Effects of Hydrogen Peroxide on Fetal Wound Repair Wound Repair and Regeneration. 13: A28-A48. DOI: 10.1111/J.1067-1927.2005.130216Bs.X |
0.735 |
|
| 2008 |
Wilgus T, Oberyszyn T, Bergdall V, Ferreira A, DiPietro L. 058
Modulation of Scar Formation by Vascular Endothelial Growth Factor Wound Repair and Regeneration. 13: A4-A27. DOI: 10.1111/J.1067-1927.2005.130215Bf.X |
0.683 |
|
| 2007 |
Duncan FJ, Wulff BC, Tober KL, Ferketich AK, Martin J, Thomas-Ahner JM, Allen SD, Kusewitt DF, Oberyszyn TM, Vanbuskirk AM. Clinically relevant immunosuppressants influence UVB-induced tumor size through effects on inflammation and angiogenesis. American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 7: 2693-703. PMID 17941958 DOI: 10.1111/J.1600-6143.2007.02004.X |
0.466 |
|
| 2007 |
Tober KL, Thomas-Ahner JM, Maruyama T, Oberyszyn TM. Possible cross-regulation of the E prostanoid receptors. Molecular Carcinogenesis. 46: 711-5. PMID 17538953 DOI: 10.1002/Mc.20347 |
0.401 |
|
| 2007 |
Oberyszyn TM. Inflammation and wound healing. Frontiers in Bioscience : a Journal and Virtual Library. 12: 2993-9. PMID 17485276 DOI: 10.2741/2289 |
0.395 |
|
| 2007 |
Thomas-Ahner JM, Wulff BC, Tober KL, Kusewitt DF, Riggenbach JA, Oberyszyn TM. Gender differences in UVB-induced skin carcinogenesis, inflammation, and DNA damage. Cancer Research. 67: 3468-74. PMID 17389759 DOI: 10.1158/0008-5472.Can-06-3798 |
0.473 |
|
| 2007 |
Hatton JL, Parent A, Tober KL, Hoppes T, Wulff BC, Duncan FJ, Kusewitt DF, VanBuskirk AM, Oberyszyn TM. Depletion of CD4+ cells exacerbates the cutaneous response to acute and chronic UVB exposure. The Journal of Investigative Dermatology. 127: 1507-15. PMID 17363918 DOI: 10.1038/Sj.Jid.5700746 |
0.774 |
|
| 2007 |
Tober KL, Thomas-Ahner JM, Kusewitt DF, Oberyszyn TM. Effects of UVB on E prostanoid receptor expression in murine skin. The Journal of Investigative Dermatology. 127: 214-21. PMID 16917495 DOI: 10.1038/Sj.Jid.5700502 |
0.453 |
|
| 2006 |
Tober KL, Wilgus TA, Kusewitt DF, Thomas-Ahner JM, Maruyama T, Oberyszyn TM. Importance of the EP(1) receptor in cutaneous UVB-induced inflammation and tumor development. The Journal of Investigative Dermatology. 126: 205-11. PMID 16417238 DOI: 10.1038/Sj.Jid.5700014 |
0.772 |
|
| 2005 |
Saul AN, Oberyszyn TM, Daugherty C, Kusewitt D, Jones S, Jewell S, Malarkey WB, Lehman A, Lemeshow S, Dhabhar FS. Chronic stress and susceptibility to skin cancer. Journal of the National Cancer Institute. 97: 1760-7. PMID 16333031 DOI: 10.1093/Jnci/Dji401 |
0.751 |
|
| 2005 |
Wilgus TA, Bergdall VK, Dipietro LA, Oberyszyn TM. Hydrogen peroxide disrupts scarless fetal wound repair. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 13: 513-9. PMID 16176460 DOI: 10.1111/J.1067-1927.2005.00072.X |
0.711 |
|
| 2004 |
Wilgus TA, Bergdall VK, Tober KL, Hill KJ, Mitra S, Flavahan NA, Oberyszyn TM. The impact of cyclooxygenase-2 mediated inflammation on scarless fetal wound healing. The American Journal of Pathology. 165: 753-61. PMID 15331400 DOI: 10.1016/S0002-9440(10)63338-X |
0.728 |
|
| 2004 |
Wilgus TA, Breza TS, Tober KL, Oberyszyn TM. Treatment with 5-fluorouracil and celecoxib displays synergistic regression of ultraviolet light B-induced skin tumors. The Journal of Investigative Dermatology. 122: 1488-94. PMID 15175041 DOI: 10.1111/J.0022-202X.2004.22606.X |
0.758 |
|
| 2003 |
Wilgus TA, Koki AT, Zweifel BS, Kusewitt DF, Rubal PA, Oberyszyn TM. Inhibition of cutaneous ultraviolet light B-mediated inflammation and tumor formation with topical celecoxib treatment. Molecular Carcinogenesis. 38: 49-58. PMID 14502644 DOI: 10.1002/Mc.10141 |
0.774 |
|
| 2003 |
Wilgus TA, Koki AT, Zweifel BS, Rubal PA, Oberyszyn TM. Chemotherapeutic efficacy of topical celecoxib in a murine model of ultraviolet light B-induced skin cancer. Molecular Carcinogenesis. 38: 33-9. PMID 12949841 DOI: 10.1002/Mc.10142 |
0.755 |
|
| 2003 |
Wilgus TA, Vodovotz Y, Vittadini E, Clubbs EA, Oberyszyn TM. Reduction of scar formation in full-thickness wounds with topical celecoxib treatment. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 11: 25-34. PMID 12581424 DOI: 10.1046/J.1524-475X.2003.11106.X |
0.722 |
|
| 2002 |
Wilgus TA, Parrett ML, Ross MS, Tober KL, Robertson FM, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 inhibitor. Advances in Experimental Medicine and Biology. 507: 85-92. PMID 12664569 DOI: 10.1007/978-1-4615-0193-0_14 |
0.776 |
|
| 2001 |
Oberyszyn TM, Robertson FM, Tober KL, Ross MS, Parrett ML, Wilgus TA, Iyer S, Woo J, Buelow R. Inhibition of cutaneous UV light-induced tumor necrosis factor-alpha protein production by Allotrap 1258, a novel immunomodulatory peptide. Photochemistry and Photobiology. 73: 184-90. PMID 11272733 DOI: 10.1562/0031-8655(2001)073<0184:Ioculi>2.0.Co;2 |
0.69 |
|
| 2000 |
Wilgus TA, Ross MS, Parrett ML, Oberyszyn TM. Topical application of a selective cyclooxygenase inhibitor suppresses UVB mediated cutaneous inflammation. Prostaglandins & Other Lipid Mediators. 62: 367-84. PMID 11060900 DOI: 10.1016/S0090-6980(00)00089-7 |
0.76 |
|
| 1999 |
Wilgus TA, Robertson FM, Parrett ML, Ross MS, Tober KL, Oberyszyn TM. Inhibition of ultraviolet light B-induced cutaneous inflammation by a specific cyclooxygenase-2 (COX-2) inhibitor Prostaglandins & Other Lipid Mediators. 59: 219. DOI: 10.1016/S0090-6980(99)90454-9 |
0.673 |
|
| 1998 |
Tober KL, Cannon RE, Spalding JW, Oberyszyn TM, Parrett ML, Rackoff AI, Oberyszyn AS, Tennant RW, Robertson FM. Comparative expression of novel vascular endothelial growth factor/vascular permeability factor transcripts in skin, papillomas, and carcinomas of v-Ha-ras Tg.AC transgenic mice and FVB/N mice. Biochemical and Biophysical Research Communications. 247: 644-53. PMID 9647747 DOI: 10.1006/Bbrc.1998.8787 |
0.352 |
|
| 1998 |
Oberyszyn TM, Tober KL, Ross MS, Robertson FM. Inhibitory effects of pentoxifylline on ultraviolet B light-induced cutaneous inflammation. Molecular Carcinogenesis. 22: 16-25. PMID 9609097 DOI: 10.1002/(Sici)1098-2744(199805)22:1<16::Aid-Mc3>3.0.Co;2-J |
0.468 |
|
| 1998 |
Oberyszyn TM, Conti CJ, Ross MS, Oberyszyn AS, Tober KL, Rackoff AI, Robertson FM. Beta2 integrin/ICAM-1 adhesion molecule interactions in cutaneous inflammation and tumor promotion. Carcinogenesis. 19: 445-55. PMID 9525279 DOI: 10.1093/Carcin/19.3.445 |
0.374 |
|
| 1996 |
Robertson FM, Long BW, Tober KL, Ross MS, Oberyszyn TM. Gene expression and cellular sources of inducible nitric oxide synthase during tumor promotion. Carcinogenesis. 17: 2053-9. PMID 8824534 DOI: 10.1093/Carcin/17.9.2053 |
0.423 |
|
| 1996 |
Robertson FM, Ross MS, Tober KL, Long BW, Oberyszyn TM. Inhibition of pro-inflammatory cytokine gene expression and papilloma growth during murine multistage carcinogenesis by pentoxifylline. Carcinogenesis. 17: 1719-28. PMID 8761432 DOI: 10.1093/Carcin/17.8.1719 |
0.429 |
|
| 1995 |
Robertson FM, Pellegrini AE, Ross MS, Oberyszyn AS, Boros LG, Bijur GN, Sabourin CL, Oberyszyn TM. Interleukin-1alpha gene expression during wound healing. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 3: 473-84. PMID 17147659 DOI: 10.1046/J.1524-475X.1995.30412.X |
0.357 |
|
| 1995 |
Nill MR, Oberyszyn TM, Ross MS, Oberyszyn AS, Robertson FM. Temporal sequence of pulmonary cytokine gene expression in response to endotoxin in C3H/HeN endotoxin-sensitive and C3H/HeJ endotoxin-resistant mice. Journal of Leukocyte Biology. 58: 563-74. PMID 7595058 DOI: 10.1002/Jlb.58.5.563 |
0.328 |
|
| 1994 |
Robertson FM, Bijur GN, Oberyszyn AS, Pellegrini AE, Boros LG, Sabourin CL, Oberyszyn TM. Granulocyte-macrophage colony stimulating factor gene expression and function during tumor promotion. Carcinogenesis. 15: 1017-29. PMID 8200063 DOI: 10.1093/Carcin/15.5.1017 |
0.418 |
|
| 1993 |
Oberyszyn TM, Sabourin CL, Bijur GN, Oberyszyn AS, Boros LG, Robertson FM. Interleukin-1 alpha gene expression and localization of interleukin-1 alpha protein during tumor promotion. Molecular Carcinogenesis. 7: 238-48. PMID 8352883 DOI: 10.1002/Mc.2940070406 |
0.316 |
|
| Show low-probability matches. |